OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

EVOTEC SE INH O.N./  DE0005664809  /

Xetra
2024-05-30  1:17:21 PM Chg. -0.010 Volume Bid1:17:52 PM Ask1:17:54 PM Market Capitalization Dividend Y. P/E Ratio
8.485EUR -0.12% 644,329
Turnover: 5.45 mill.		 8.480Bid Size: 1,235 8.490Ask Size: 1,809 1.51 bill.EUR - -
GlobeNewswire 05-14 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GlobeNewswire 2023-12-11 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire 2023-11-07 Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire 2020-08-20 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
GlobeNewswire 2019-02-07 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 2019-02-07 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 2018-02-15 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire 2018-01-08 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire 2017-09-14 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire 2011-11-29 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 2011-11-10 Evotec reports nine months results: Upside materialising
GlobeNewswire 2011-11-03 Evotec to Report Third Quarter Results on 10 November 2011
GlobeNewswire 2011-10-27 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
GlobeNewswire 2011-10-20 Evotec and APEIRON Biologics start next project on the Cbl-b target
GlobeNewswire 2011-10-05 Evotec announces second multi-target collaboration with UCB
GlobeNewswire 2011-09-29 Evotec acquires remaining 30% of Indian Joint Venture from DIL
GlobeNewswire 2011-09-09 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 2011-09-05 Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
GlobeNewswire 2011-09-05 Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...
GlobeNewswire 2011-08-18 Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...
GlobeNewswire 2011-08-11 Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised
GlobeNewswire 2011-08-11 Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company
GlobeNewswire 2011-08-04 Evotec to Report Second Quarter 2011 Results on 11 August 2011
GlobeNewswire 2011-07-07 Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases
GlobeNewswire 2011-06-30 Total voting rights:Evotec AG:Evotec AG: Publication pursuant to §26a WpHG (the German Securities Tr...